GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B6904 L-803,087 trifluoroacetateSummary: somatostatin sst4 receptor agonist -
B6905 L-817,818Summary: somatostatin sst5 receptor agonist -
B6906 PNU 142633Summary: 5-HT1D receptor agonist -
B6933 IloprostSummary: A prostacyclin (PGI2) analog acting as an agonist of IP, EP1 and EP3 receptors -
B6943 Exendin-3 (9-39) amide1 CitationTarget: Glucagon-like peptide 1 (GLP-1) receptorsSummary: GLP-1 receptor antagonist -
B6977 2-PalmitoylglycerolSummary: Endogenous fatty acid glycerol ester -
B6993 [Des-octanoyl]-Ghrelin (human)Summary: Non-acylated, major circulating isoform of ghrelin -
B6994 L-692,585Summary: ghrelin receptor (GHS-R1a) agonist -
B6999 FPL 55712Summary: Leukotriene receptor antagonist -
B7000 2'-MeCCPASummary: A1 adenosine receptor agonist

